The mRNA expression of SETD2 in human breast cancer: correlation with clinico-pathological parameters
about
Histone methyltransferase SETD2 coordinates FACT recruitment with nucleosome dynamics during transcriptionGenetic and Chromosomal Aberrations and Their Clinical Significance in Renal NeoplasmsAdverse outcomes in clear cell renal cell carcinoma with mutations of 3p21 epigenetic regulators BAP1 and SETD2: a report by MSKCC and the KIRC TCGA research networkSETD2: an epigenetic modifier with tumor suppressor functionalityThe mutational landscape of chromatin regulatory factors across 4,623 tumor samples.mRNA expression of DOK1-6 in human breast cancerHow kinesin motor proteins drive mitotic spindle function: Lessons from molecular assays.SETD2-dependent histone H3K36 trimethylation is required for homologous recombination repair and genome stabilitymiR-106b-5p targets tumor suppressor gene SETD2 to inactive its function in clear cell renal cell carcinoma.A histone H3K36 chromatin switch coordinates DNA double-strand break repair pathway choice.Reduced expression of SETD2 and SNX9 proteins in chemically induced mammary tumorigenesis in Wistar rats: a prognostic histological and proteomic study.Identification and Verification of Potential Therapeutic Target Genes in Berberine-Treated Zucker Diabetic Fatty Rats through Bioinformatics AnalysisInhibiting WEE1 Selectively Kills Histone H3K36me3-Deficient Cancers by dNTP Starvation.LncRNA HOTAIR promotes human liver cancer stem cell malignant growth through downregulation of SETD2.Clinical and pathologic impact of select chromatin-modulating tumor suppressors in clear cell renal cell carcinoma.Mutations in epigenetic regulators are involved in acute lymphoblastic leukemia relapse following allogeneic hematopoietic stem cell transplantation.Type II enteropathy-associated T-cell lymphoma features a unique genomic profile with highly recurrent SETD2 alterations.SPOP-containing complex regulates SETD2 stability and H3K36me3-coupled alternative splicing.Chromatin regulators with tumor suppressor properties and their alterations in human cancers.BAP1, PBRM1 and SETD2 in clear-cell renal cell carcinoma: molecular diagnostics and possible targets for personalized therapies.Identification of SETD2-NF1 fusion gene in a pediatric spindle cell tumor with the chromosomal translocation t(3;17)(p21;q12).Marked for death: targeting epigenetic changes in cancer.Structure/Function Analysis of Recurrent Mutations in SETD2 Protein Reveals a Critical and Conserved Role for a SET Domain Residue in Maintaining Protein Stability and Histone H3 Lys-36 TrimethylationDynamic reprogramming of DNA methylation in SETD2-deregulated renal cell carcinoma.H3K36 methyltransferases as cancer drug targets: rationale and perspectives for inhibitor developmentThe epigenetic landscape of renal cancer.SETting the Stage for Cancer Development: SETD2 and the Consequences of Lost Methylation.Genetic heterogeneity and chromatin modifiers in renal clear cell carcinoma.Functional role of SETD2, BAP1, PARP-3 and PBRM1 candidate genes on the regulation of hTERT gene expressionHistone methyltransferase SETD2 modulates alternative splicing to inhibit intestinal tumorigenesis.Spurious transcription and its impact on cell function.Evidence for a pro-apoptotic function of RACK1 in human breast cancer.Profiling plasma extracellular vesicle by pluronic block-copolymer based enrichment method unveils features associated with breast cancer aggression, metastasis and invasion.
P2860
Q24309566-694E02F0-8A46-4957-B44F-AA427CF787BEQ26785930-5809D782-4F89-4542-972B-348275B56291Q27852242-4F1A6D8B-790B-4111-A33C-91AD6D551972Q28075731-56839541-7934-4146-8F3A-BC4F513F1166Q30580509-9939B304-9FCF-487F-B1D3-FD4AF17BD8FFQ33585060-8F40425E-619F-4D6A-A22B-30952A894371Q33749289-59521F62-3751-4D81-A61C-AECF44528B9FQ35188529-72D9836D-64F9-419F-8016-1AFD0F0D494EQ35551941-D7BD31BD-827D-4B90-80E7-BFDA38CD480EQ35949908-2890190A-5DC2-47E8-88B8-B27DF4A9F24CQ36170166-DE6A0261-752C-44E9-8EF7-97819DF989F9Q36192941-C5CCD0E6-F91F-4200-84D7-6350EFB3FD66Q36275644-2BF5DCDC-8ABA-4BE2-BA50-9B0BA689840EQ36413923-0A32180B-396D-4CCA-8833-14986ACA1F44Q36736210-E8476C74-F37B-42EC-9DA3-550EDE70F212Q36771918-674A40F1-7009-44F4-B9F4-A1CFA77F8363Q37257158-8346C29B-B534-442B-B260-1E50672EE383Q37577424-C8676BF8-57F1-49F9-B7D1-9352575B53E2Q38058125-949D58BF-2171-4F1F-9C93-D49D0C6F70E2Q38545726-0F550CD3-8461-4ED8-938D-1444B10CE2B0Q38684605-B91B75F1-DF30-4624-BE2A-D3E6AA32E7F7Q38747872-21BCD7EE-374C-4C12-B7C2-4289235FE459Q38751593-B7008EC1-5F8A-4D15-82FC-C02425E33723Q38813611-56A316B3-90EA-44AC-84BA-9A4524968BA8Q38829055-0151952C-A1F0-42C2-BFD9-62430CBD28BDQ39021700-1C7E68EA-6603-4B90-91B8-F78077029BCEQ39118911-9F29E56F-283E-4F88-8B95-47C3F543A810Q39866397-A7487755-DE1D-440D-9F88-C3319145C9B2Q42365306-29DBB414-E4BB-44C4-9CBF-DAC8E57BD317Q47927828-87ACB334-F8CD-44FA-A053-CC089290D862Q49584282-1832241C-E91D-4F02-AFB5-EC2578D35909Q54416120-4FD4CA24-9481-45BF-B954-103F7931D042Q55383954-A607B0F6-C0D5-4EE9-89FE-CE42969B329F
P2860
The mRNA expression of SETD2 in human breast cancer: correlation with clinico-pathological parameters
description
2009 nî lūn-bûn
@nan
2009 թուականին հրատարակուած գիտական յօդուած
@hyw
2009 թվականին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
The mRNA expression of SETD2 i ...... linico-pathological parameters
@ast
The mRNA expression of SETD2 i ...... linico-pathological parameters
@en
The mRNA expression of SETD2 i ...... linico-pathological parameters
@en-gb
The mRNA expression of SETD2 i ...... linico-pathological parameters
@nl
type
label
The mRNA expression of SETD2 i ...... linico-pathological parameters
@ast
The mRNA expression of SETD2 i ...... linico-pathological parameters
@en
The mRNA expression of SETD2 i ...... linico-pathological parameters
@en-gb
The mRNA expression of SETD2 i ...... linico-pathological parameters
@nl
prefLabel
The mRNA expression of SETD2 i ...... linico-pathological parameters
@ast
The mRNA expression of SETD2 i ...... linico-pathological parameters
@en
The mRNA expression of SETD2 i ...... linico-pathological parameters
@en-gb
The mRNA expression of SETD2 i ...... linico-pathological parameters
@nl
P2093
P2860
P3181
P356
P1433
P1476
The mRNA expression of SETD2 i ...... linico-pathological parameters
@en
P2093
P2860
P2888
P3181
P356
10.1186/1471-2407-9-290
P407
P50
P577
2009-08-21T00:00:00Z
P5875
P6179
1039533136